Innovative Nanoparticle-based Therapeutic Strategies: Overcoming Biological Barriers for Enhanced Efficacy

The Blood-Brain Barrier (BBB) poses a formidable challenge for drug delivery to the Central Nervous System (CNS) due to its selective permeability and robust defense mechanisms. This review provides a comprehensive examination of the anatomical structure, physiology, and physiological challenges of the BBB, along with innovative approaches for overcoming these barriers to enhance CNS drug delivery. The BBB is primarily composed of endothelial cells, pericytes, and astrocytic end-feet, reinforced by tight junctions that tightly regulate the passage of substances into the brain parenchyma. Various transport mechanisms, including carrier-mediated transport, receptor-mediated transport (e.g., via LDL and transferrin receptors), absorptive-mediated transport, and active efflux transport, govern the selective influx and efflux of molecules across the BBB to maintain CNS homeostasis. Biological approaches harness endogenous transport mechanisms to facilitate drug delivery across the BBB, while chemical approaches leverage nanotechnology to engineer nanoparticles capable of traversing the barrier. These include liposomes, solid-lipid nanoparticles, polymeric nanoparticles, and inorganic nanoparticles, each designed with specific parameters such as particle size, shape, and surface charge to optimize drug delivery. Drug loading strategies, such as covalent bonding and non-covalent adsorption, enhance the encapsulation and release of therapeutic agents from nanoparticles. Furthermore, the incorporation of ligands facilitates receptor targeting and protein corona formation, enhancing nanoparticle properties and improving BBB penetration. By synthesizing recent advancements in BBB permeation strategies, this review aims to provide insights into the development of effective therapies for neurological disorders, ultimately advancing the field of CNS drug delivery.